SARCOPENIA AND MYOSTEATOSIS AT PRESENTATION ADVERSELY AFFECT SURVIVAL AFTER ESOPHAGECTOMY FOR ESOPHAGEAL CANCER. Radiol Oncol 2020, 54 (2), 237-246.